Florida’s Adult-Use Cannabis Rollout: Timeline, Winners, and What It Means for Your Portfolio
By Sheeba M. | April 15, 2026 Florida’s Adult-Use Cannabis Rollout: Timeline, Winners, and What It Means for Your Portfolio TL;DR: Florida’s cannabis market could reach $6 billion annually by 2028. The early movers — Trulieve, Surterra, and connected MSOs — are positioned to capture the bulk of that upside. Here’s what you need to […]
Why Tilray Brands Could Be the Cannabis Stock Bargain of 2026
By Sheeba M. | April 15, 2026 Why Tilray Brands Could Be the Cannabis Stock Bargain of 2026 TL;DR: Tilray’s multi-national footprint and recent operational streamlining position it uniquely for the next U.S. federal reform wave. At current valuations, TLRY may be the most undervalued play in cannabis. When Tilray Brands (NASDAQ: TLRY) completed its […]
VRNO stock, a leading provider of virtual reality experiences, has seen significant growth and is poised for continued innovation in the VR market.
TL;DR VRNO stock, a leading provider of virtual reality experiences, has seen significant growth and is poised for continued innovation in the VR market. The Bottom Line The cannabis industry has experienced rapid growth due to increasing legalization in many countries. Companies like VRNO are capitalizing on this trend by developing innovative technology that combines […]
Canadian Cannabis LPs Are Mounting a Comeback — Here’s Why Now
By Sheeba M. | April 15, 2026 Canadian Cannabis LPs Are Mounting a Comeback — Here’s Why Now TL;DR: After years of writedowns and retreat, Canadian licensed producers are finding their footing in medical cannabis exports and biotech derivatives. Canopy Growth (CGC) and Organigram (OGI) are quietly positioning for a comeback. The narrative around Canadian […]
Cannabis MSO Revenue Trends: Why Q1 2026 Could Be the Turning Point
By Sheeba M. | April 15, 2026 Cannabis MSO Revenue Trends: Why Q1 2026 Could Be the Turning Point TL;DR: Multi-state operators are posting their strongest quarterly revenues in years. Vertical integration and state-level rec markets are driving the beat — but margins remain thin. Here’s what to watch in Q1 2026 numbers. The cannabis […]
CURLF is a cannabis-focused biotech company developing non-psychoactive compounds for pain relief and other therapeutic applications.
TL;DR CURLF is a cannabis-focused biotech company developing non-psychoactive compounds for pain relief and other therapeutic applications. The Bottom Line The cannabis industry has seen rapid growth in recent years, driven by increasing legalization and consumer demand. CURLF is one of several companies focused on advancing the field of cannabis therapeutics. Key Points CURLF’s primary […]
OGI, a leading cannabis producer, has experienced robust growth and is expected to continue its dominance in the market.
TL;DR OGI, a leading cannabis producer, has experienced robust growth and is expected to continue its dominance in the market. The Bottom Line The cannabis industry has seen rapid expansion in recent years due to increased legalization in various states, offering an attractive investment opportunity for investors. OGI stands out as one of the largest […]
Cannabis M&A Activity Heats Up: Why Major Players Are Racing to Consolidate
By Sheeba M. | April 14, 2026 Cannabis M&A Activity Heats Up: Why Major Players Are Racing to Consolidate TL;DR: With small-batch operators running out of cash and institutional capital drying up, expect a wave of distressed acquisitions — and MSOs positioned with dry powder will be the biggest winners. The cannabis consolidation wave isn’t […]
Vertical Integration Is the MSO Battleground — Here’s Why It Matters for Your Portfolio
By Sheeba M. | April 14, 2026 Vertical Integration Is the MSO Battleground — Here’s Why It Matters for Your Portfolio TL;DR: MSOs locking up cultivation, manufacturing, and retail under one roof are capturing 40-60% higher margins than peers — a structural advantage that won’t fade with market volatility. The cannabis industry’s most consequential strategic […]
Organigram Holdings Quietly Expands Canadian Medical Footprint as Edibles Pivot Continues
By Sheeba M. | April 14, 2026 Organigram Holdings Quietly Expands Canadian Medical Footprint as Edibles Pivot Continues TL;DR: Organigram’s pivot to recreational edibles is losing steam, but a quiet push into medical cannabis partnerships could provide the revenue stability the company needs. Organigram Holdings has spent the better part of two years repositioning itself […]